Skip to search formSkip to main contentSkip to account menu

LAMA2 gene

Known as: LAMININ 2, HEAVY CHAIN, MEROSIN, LAMA2 
National Institutes of Health

Related topics

Related topics

2 relations
Congenital muscular dystrophy (disorder)laminin alpha 2

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Two novel COL 6 A 3 mutations disrupt extracellular matrix formation and lead to myopathy from Ullrich congenital muscular dystrophy and Bethlem myopathy spectrum
  • Jun
  • 2018
  • Corpus ID: 51989676
Here we present a case report of collagen VI related myopathy in a patient, 8 ​y.o. boy, with intermediate phenotype between… 
2016
2016
Pressure-support ventilation in a child with merosin-deficient congenital muscular dystrophy under sevoflurane anesthesia.
Merosin-deficient congenital muscular dystrophy (MD-CMD) is the most common and severe form of congenital muscular dystrophy and… 
2016
2016
Aquatic physical therapy in the treatment of a child with merosin-deficient congenital muscular dystrophy: case report
This case report describes an aquatic therapy program for a child with Merosin-Deficient Congenital Muscular Dystrophy. Objective… 
2013
2013
Sensitivity alteration of fiber Bragg grating sensors through on-fiber metallic coatings produced by a combined laser-assisted maskless microdeposition and electroless plating process
2009
2009
When new exons are born
I n contrast to the common belief before the genomic era, we now know that new exons are frequently ‘born’ in the genomes of… 
2006
2006
LAMA2 gene analysis in congenital muscular dystrophy: New mutations, prenatal diagnosis, and founder effect
Objective: To determine if laminin-α2 deficiency is due to mutations in the LAMA2 gene or secondary to mutations in other… 
1994
1994
Corrigendum: Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31–33
T. Toda, M. Segawa, Y. Nomura, I. Nonaka, K. Masuda, T. Ishihara, M. Sakai, I. Tomita, Y. Origuchi, K. Ohno, N. Misugi, Y. Sasaki… 
1986
1986
AMP deaminase activity of skeletal muscle in neuromuscular disorders in childhood. Histochemical and biochemical studies.
We studied the histochemical staining and biochemical activity of AMP deaminase in biopsied muscle in Becker-type muscular… 
1984
1984
[Causes of death in Fukuyama congenital muscular dystrophy].
1977
1977
[Etiology of congenital muscular dystrophy (Fukuyama type)].